Key Wall Street Updates

Here are some significant announcements from Wall Street on Tuesday:

• Wedbush: Upgraded TripAdvisor from neutral to outperform, citing the stock’s undervaluation. They highlighted five key factors for this perspective, including governance changes following the LTRIP merger set for April 2025 and activist involvement from Starboard Value, which holds over 9% of shares and has a cooperative agreement for board seats.
• Susquehanna: Upgraded Knight-Swift from neutral to positive. They noted that the outlook for their asset-based truckload (TL) and less-than-truckload (LTL) revenue remains strong, though they cautioned some good news might already be priced in. They favor Knight-Swift as a means to capitalize on undervalued LTL options.
• Daiwa: Stated they continue to favor NVIDIA, describing their impressions of the company’s recent keynote and GTC event as positive amid a very competitive landscape.
• Goldman Sachs: Announced it is initiating coverage of Movia Medical, calling it a company with significant upside potential. They set a buy rating with a target price of $31, suggesting a potential increase of 130%.
• UBS: Downgraded Sherwin-Williams from buy to neutral due to concerns about the housing market’s stability. They conveyed that while the company’s earnings are crucial to the U.S. housing recovery, current market conditions could delay that recovery timeline.
• Deutsche Bank: Expressed a bullish outlook on real estate investment trusts, particularly after upgrading Macerich. They believe most portfolio simplifications and balance sheet improvements are nearly complete, which has largely accounted for earnings dilution.
• Piper Sandler: Highlighted the anticipated release of Grand Theft Auto (GTA) 6 as potentially monumental for entertainment, launching coverage of Take-Two Interactive (TTWO) with an outperform rating and a $280 price target.
• JPMorgan: Initiated coverage of ODTX, noting the biotech company’s promising potential.
• Goldman Sachs: Downgraded Intuit from neutral to sell, citing deteriorating fundamentals and concerns about heightened tax competition, mentioning that much of this decline is reflected in the stock’s 46% year-to-date drop versus the S&P’s 11% gain.
• Goldman Sachs: Upgraded Neurocrine Biosciences back to buy, praising the company’s growth trajectory and setting a price target of $213.
• Canaccord: Began coverage of Enhanced Health, noting its strong positioning in the telehealth space, initiating with a buy rating and a price target of $6.
• UBS: Initiated coverage of Seven Hills Realty Trust, issuing a buy rating with a target price of $10, emphasizing the REIT’s advantageous position.
• Deutsche Bank: Reiterated its acquisition rating for GE Aerospace, raising the price target to $380 based on higher 2028 EPS estimates.
• Loop: Upgraded Hewlett-Packard Enterprise from hold to buy after their earnings report, noting significant growth and operational expansion, raising the price target to $75 from $23.
• Raymond James: Upgraded Atlas Energy Solutions, recommending the energy company despite a challenging first quarter in 2026, indicating improved clarity on future growth plans.
• HSBC: Maintained a buy rating on Alphabet, lowering its price target to $420 but reaffirmed confidence in the company’s position to benefit from AI advancements.
• Evercore ISI: Upgraded Guardant Health from traditional to outperform, indicating positive catalysts ahead and setting a target price of $160.
• Bernstein: Continued to support Ferrari’s strong performance, calling them a “master of the game.” Despite fluctuations in stock prices following the Luce electric car launch, they’ve identified renewed strength, initiating coverage of MIRM with a buy/high-risk rating and a target price of $145.